Bioventus (BVS) Non-Current Deferred Tax Liability (2020 - 2026)
Bioventus' (BVS) quarterly Non-Current Deferred Tax Liability came in at $568000.0 in Q1 2026, down 6.43% YoY from $607000.0 in Q1 2025, and up 31.18% on a QoQ basis from $433000.0 in Q4 2025.
Bioventus (BVS) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $568000.0 in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability fell 6.43% year-over-year to $568000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $568000.0 (down 6.43% YoY) and the FY2025 annual result came in at $433000.0, down 23.23% from the prior year.
- Non-Current Deferred Tax Liability climbed to $568000.0 in Q1 2026, from $433000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $159.3 million in Q4 2022 to a low of $351000.0 in Q2 2023.
- A 5-year average of $29.5 million and a median of $786000.0 in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability tumbled 99.7% — and 2024, when it jumped 268.66%.
- Tracing BVS's Non-Current Deferred Tax Liability over 5 years: stood at $2.2 million in 2022, then retreated by 8.67% to $2.1 million in 2023, then plunged by 72.53% to $564000.0 in 2024, then slipped by 23.23% to $433000.0 in 2025, then jumped by 31.18% to $568000.0 in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $568000.0 (Q1 2026), $433000.0 (Q4 2025), and $786000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Bioventus | 972.23 Mn | 942.77 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 568,000.00 |
| Jun 27, 2026 | 568,000.00 |
| Mar 28, 2026 | 568,000.00 |
| Mar 28, 2026 | 568,000.00 |
| Dec 31, 2025 | 433,000.00 |
| Dec 31, 2025 | 433,000.00 |
| Sep 27, 2025 | 786,000.00 |
| Sep 27, 2025 | 786,000.00 |
| Jun 28, 2025 | 651,000.00 |
| Jun 28, 2025 | 651,000.00 |
| Mar 29, 2025 | 607,000.00 |
| Mar 29, 2025 | 607,000.00 |
| Dec 31, 2024 | 564,000.00 |
| Dec 31, 2024 | 564,000.00 |
| Mar 30, 2024 | 1.29 Mn |
| Mar 30, 2024 | 1.29 Mn |
| Dec 31, 2023 | 2.05 Mn |
| Dec 31, 2023 | 2.05 Mn |
| Apr 1, 2023 | 351,000.00 |
| Apr 1, 2023 | 351,000.00 |